GASTRIC CANCER STAGE II

GASTRIC CANCER STAGE II was reported 750 times

GASTRIC CANCER STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 3 0.0044
1 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
2 Cephalosporin Antibacterial [EPC] 1 0.0001
3 Non-narcotic Antitussive [EPC] 1 0.0001
4 Nitrofuran Antibacterial [EPC] 1 0.0001
5 Alkaloid [EPC] 1 0.0000
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
8 Histamine-2 Receptor Antagonist [EPC] 4 0.0000
9 Tetracycline-class Drug [EPC] 2 0.0000
10 Interleukin-17A Antagonist [EPC] 1 0.0000
11 Fluoroquinolone Antibacterial [EPC] 2 0.0000
12 Prostaglandin Analog [EPC] 1 0.0000
13 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
14 Aminosalicylate [EPC] 1 0.0000
15 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
16 Sulfonylurea [EPC] 1 0.0000
17 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
18 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
19 alpha-Adrenergic Blocker [EPC] 1 0.0000
20 Calcium [EPC] 1 0.0000
21 Aldosterone Antagonist [EPC] 1 0.0000
22 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
23 Interferon beta [EPC] 1 0.0000
24 Expectorant [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Loop Diuretic [EPC] 2 0.0000
27 Factor Xa Inhibitor [EPC] 1 0.0000
28 Proton Pump Inhibitor [EPC] 2 0.0000
29 beta-Adrenergic Blocker [EPC] 1 0.0000
30 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
31 Corticosteroid [EPC] 4 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Vitamin C [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
35 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
36 Benzodiazepine [EPC] 1 0.0000
37 Tumor Necrosis Factor Blocker [EPC] 1 0.0000